Aquaporin modulators: a patent review (2010–2015)

References

• Soveral G, Nielsen S, Casini A. Aquaporins in health and disease: new molecular targets for drug discovery. Boca Raton (FL): CRC Press, Taylor & Francis Group; 2016.
   Google Scholar
• Carbrey JM, Agre P. Discovery of the aquaporins and development of the field. In: Beitz E, editor. Handbook of experimental pharmacology. Berlin: Springer Verlag; 2009. p. 3–28.
   Google Scholar
• Yasui M, Hazama A, Kwon TH, et al. Rapid gating and anion permeability of an intracellular aquaporin. Nature. 1999 Nov 11;402(6758):184–187.
   PubMed Web of Science ®Google Scholar
• Soria LR, Fanelli E, Altamura N, et al. Aquaporin-8-facilitated mitochondrial ammonia transport. Biochem Biophys Res Commun. 2010 Mar 5;393(2):217–221.
   PubMed Web of Science ®Google Scholar
• Bienert GP, Chaumont F. Aquaporin-facilitated transmembrane diffusion of hydrogen peroxide. Biochim Biophys Acta. 2014 May;1840(5):1596–1604.
   PubMed Web of Science ®Google Scholar
• Ishibashi K, Tanaka Y, Morishita Y. The role of mammalian superaquaporins inside the cell. Biochim Biophys Acta. 2014 May;1840(5):1507–1512.
   PubMed Web of Science ®Google Scholar
• King LS, Kozono D, Agre P. From structure to disease: the evolving tale of aquaporin biology. Nat Rev Mol Cell Biol. 2004 Sep;5(9):687–698.
   PubMed Web of Science ®Google Scholar
• Murata K, Mitsuoka K, Hirai T, et al. Structural determinants of water permeation through aquaporin-1. Nature. 2000 Oct 5;407(6804):599–605.
   PubMed Web of Science ®Google Scholar
• Wu B, Beitz E. Aquaporins with selectivity for unconventional permeants. Cell Mol Life Sci. 2007 Sep;64(18):2413–2421.
   PubMed Web of Science ®Google Scholar
• Yool AJ, Campbell EM. Structure, function and translational relevance of aquaporin dual water and ion channels. Mol Aspects Med. 2012 Oct-Dec;33(5–6):553–561.
   PubMed Web of Science ®Google Scholar
• Savage DF, O’Connell JD 3rd, Miercke LJ, et al. Structural context shapes the aquaporin selectivity filter. Proc Natl Acad Sci U S A. 2010 Oct 5;107(40):17164–17169.
   PubMed Web of Science ®Google Scholar
• Agre P, Kozono D. Aquaporin water channels: molecular mechanisms for human diseases. FEBS Lett. 2003 Nov 27;555(1):72–78.
   PubMed Web of Science ®Google Scholar
• Verkman AS. Aquaporins at a glance. J Cell Sci. 2011 Jul 1;124(Pt 13):2107–2112.
   PubMed Web of Science ®Google Scholar
• Verkman AS. Aquaporins in clinical medicine. Annu Rev Med. 2012;63:303–316.
   PubMed Web of Science ®Google Scholar
• Nielsen S, Chou CL, Marples D, et al. Vasopressin increases water permeability of kidney collecting duct by inducing translocation of aquaporin-CD water channels to plasma membrane. Proc Natl Acad Sci U S A. 1995 Feb 14;92(4):1013–1017.
   PubMed Web of Science ®Google Scholar
• Nielsen S, Kwon TH, Frokiaer J, et al. Key roles of renal aquaporins in water balance and water-balance disorders. News Physiol Sci. 2000 Jun;15:136–143.
   PubMedGoogle Scholar
• Robben JH, Knoers NV, Deen PM. Cell biological aspects of the vasopressin type-2 receptor and aquaporin 2 water channel in nephrogenic diabetes insipidus. Am J Physiol Renal Physiol. 2006 Aug;291(2):F257–70.
   PubMed Web of Science ®Google Scholar
• Vukicevic T, Schulz M, Faust D, et al. The trafficking of the water channel aquaporin-2 in renal principal cells-a potential target for pharmacological intervention in cardiovascular diseases. Front Pharmacol. 2016;7:23.
   PubMed Web of Science ®Google Scholar
• Nielsen S, Kwon TH, Frokiaer J, et al. Regulation and dysregulation of aquaporins in water balance disorders. J Intern Med. 2007 Jan;261(1):53–64.
   PubMed Web of Science ®Google Scholar
• Laforenza U, Bottino C, Gastaldi G. Mammalian aquaglyceroporin function in metabolism. Biochim Biophys Acta. 2016 Jan;1858(1):1–11.
   PubMed Web of Science ®Google Scholar
• Mendez-Gimenez L, Rodriguez A, Balaguer I, et al. Role of aquaglyceroporins and caveolins in energy and metabolic homeostasis. Mol Cell Endocrinol. 2014 Nov;397(1–2):78–92.
   PubMed Web of Science ®Google Scholar
• Rodriguez A, Catalan V, Gomez-Ambrosi J, et al. Aquaglyceroporins serve as metabolic gateways in adiposity and insulin resistance control. Cell Cycle. 2011 May 15;10(10):1548–1556.
   PubMed Web of Science ®Google Scholar
• Madeira A, Moura TF, Soveral G. Aquaglyceroporins: implications in adipose biology and obesity. Cell Mol Life Sci. 2015 Feb;72(4):759–771.
   PubMed Web of Science ®Google Scholar
• Madeira A, Fernandez-Veledo S, Camps M, et al. Human aquaporin-11 is a water and glycerol channel and localizes in the vicinity of lipid droplets in human adipocytes. Obesity (Silver Spring). 2014 Sep;22(9):2010–2017.
   PubMed Web of Science ®Google Scholar
• Rodriguez A, Moreno NR, Balaguer I, et al. Leptin administration restores the altered adipose and hepatic expression of aquaglyceroporins improving the non-alcoholic fatty liver of ob/ob mice. Sci Rep. 2015;5:12067.
   PubMed Web of Science ®Google Scholar
• Rodriguez A, Gena P, Mendez-Gimenez L, et al. Reduced hepatic aquaporin-9 and glycerol permeability are related to insulin resistance in non-alcoholic fatty liver disease. Int J Obes (Lond). 2014 Sep;38(9):1213–1220.
   PubMed Web of Science ®Google Scholar
• Lee DH, Park DB, Lee YK, et al. The effects of thiazolidinedione treatment on the regulations of aquaglyceroporins and glycerol kinase in OLETF rats. Metabolism. 2005 Oct;54(10):1282–1289.
   PubMed Web of Science ®Google Scholar
• Guo M, Chen F, Lin T, et al. Apelin-13 decreases lipid storage in hypertrophic adipocytes in vitro through the upregulation of AQP7 expression by the PI3K signaling pathway. Med Sci Monit. 2014;20:1345–1352.
   PubMed Web of Science ®Google Scholar
• Jelen S, Wacker S, Aponte-Santamaria C, et al. Aquaporin-9 is the primary route of hepatocyte glycerol uptake for glycerol gluconeogenesis in mice. J Biol Chem. 2011 Dec 30;286(52):44319–44325.
   PubMed Web of Science ®Google Scholar
• Hara-Chikuma M, Verkman AS. Aquaporin-3 functions as a glycerol transporter in mammalian skin. Biol Cell. 2005 Jul;97(7):479–486.
   PubMed Web of Science ®Google Scholar
• Hara-Chikuma M, Verkman AS. Roles of aquaporin-3 in the epidermis. J Invest Dermatol. 2008 Sep;128(9):2145–2151.
   PubMed Web of Science ®Google Scholar
• Galan-Cobo A, Ramirez-Lorca R, Echevarria M. Role of aquaporins in cell proliferation: what else beyond water permeability? Channels. 2016 May 3;10(3):185–201.
   PubMed Web of Science ®Google Scholar
• Papadopoulos MC, Saadoun S. Key roles of aquaporins in tumor biology. Biochim Biophys Acta. 2015 Oct;1848(10 Pt B):2576–2583.
   PubMed Web of Science ®Google Scholar
• Wang J, Feng L, Zhu Z, et al. Aquaporins as diagnostic and therapeutic targets in cancer: how far we are? J Transl Med. 2015;13:96.
   PubMed Web of Science ®Google Scholar
• Verkman AS, Anderson MO, Papadopoulos MC. Aquaporins: important but elusive drug targets. Nat Rev Drug Discov. 2014 Apr;13(4):259–277.
   PubMed Web of Science ®Google Scholar
• Direito I, Madeira A, Brito MA, et al. Aquaporin-5: from structure to function and dysfunction in cancer. Cell Mol Life Sci. 2016 Apr;73(8):1623–1640.
   PubMed Web of Science ®Google Scholar
• Moon C, Soria JC, Jang SJ, et al. Involvement of aquaporins in colorectal carcinogenesis. Oncogene. 2003 Oct 2;22(43):6699–6703.
   PubMed Web of Science ®Google Scholar
• Liu YL, Matsuzaki T, Nakazawa T, et al. Expression of aquaporin 3 (AQP3) in normal and neoplastic lung tissues. Hum Pathol. 2007 Jan;38(1):171–178.
   PubMed Web of Science ®Google Scholar
• Huang Y, Zhu Z, Sun M, et al. Critical role of aquaporin-3 in the human epidermal growth factor-induced migration and proliferation in the human gastric adenocarcinoma cells. Cancer Biol Ther. 2010 Jun;9(12):1000–1007.
   PubMed Web of Science ®Google Scholar
• Niu D, Kondo T, Nakazawa T, et al. Expression of aquaporin3 in human neoplastic tissues. Histopathology. 2012 Oct;61(4):543–551.
   PubMed Web of Science ®Google Scholar
• Kang BW, Kim JG, Lee SJ, et al. Expression of aquaporin-1, aquaporin-3, and aquaporin-5 correlates with nodal metastasis in colon cancer. Oncology. 2015;88(6):369–376.
   PubMed Web of Science ®Google Scholar
• Song J, Mak E, Wu B, et al. Parasite aquaporins: current developments in drug facilitation and resistance. Biochim Biophys Acta. 2014 May;1840(5):1566–1573.
   PubMed Web of Science ®Google Scholar
• Papadopoulos MC, Verkman AS. Aquaporin 4 and neuromyelitis optica. Lancet Neurol. 2012 Jun;11(6):535–544.
   PubMed Web of Science ®Google Scholar
• Papadopoulos MC, Bennett JL, Verkman AS. Treatment of neuromyelitis optica: state-of-the-art and emerging therapies. Nat Reviews Neurol. 2014 Sep;10(9):493–506.
   PubMed Web of Science ®Google Scholar
• Fu-Jen Catholic University T. Compound used to prevent diseases caused by aquaporin deficiency. US2013137766. 2013.
   Google Scholar
• Aeromics L, US. New methods. WO2013169939. 2013.
   Google Scholar
• University of Lisbon P. Inhibitors of aquaglyceroporins, methods and uses therof. WO2013005170. 2013.
   Google Scholar
• University of Arizona U. Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance. US8835491 /WO2008052190. 2014.
   Google Scholar
• Osteobuild Lda J. Modulation of osteoclast differentiation. US8835390. 2014.
   Google Scholar
• Aeromics LLC U. Novel methods. WO2015069948. 2015.
   Google Scholar
• Aeromics LLC U. Novel formulations. WO2015069956. 2015.
   Google Scholar
• Washington University U. Methods of renal cancer detection. WO2010135334. 2010.
   Google Scholar
• Corthera I, US. Modulating aquaporins with relaxin. WO2011112791. 2012.
   Google Scholar
• University of Colorado U. Compositions and methods for the treatment of neuromyelitis optica. WO2012145746. 2012.
   Google Scholar
• University of California and University of Colorado U. Compositions and methods for the treatment of neuromyelitis optica. US20140170140. 2014.
   Google Scholar
• EuroImunn Mediziniche Labordiagnostika A, DE. Diagnostic kit and method for examining a human patient sample for the presence of antibodies specific to neuromyelitis optica. WO2012110024. 2012.
   Google Scholar
• Agency for Science TaR, Singapore. Method for differentiating embryonic stem cells into cells expressing AQP1. US8481316 /WO2009/011663. 2013.
   Google Scholar
• Tzartos G. Biomarker. WO2013057599. 2013.
   Google Scholar
• Mount Sinai School of Medicine N, US. A method to distinguish benign from malignant oncocytic cell tisue. WO2013116537. 2013.
   Google Scholar
• Governement U. Vaccination of animals to elicit a protective immune response against tick infestations and tick-borne pathogens transmission. WO2013177142. 2013.
   Google Scholar
• Protagen AD. Method for diagnosis of neuromyelitis optica. WO2014154907. 2014.
   Google Scholar
• The Scripps research Institute U. Peptoids that bind specific antigens. WO2014127111. 2014.
   Google Scholar
• University of California U. Aquaporin-4 peptides, compositions and methods of use. US2014199333. 2014.
   Google Scholar
• Goverment U. Vaccination of companion animals to elicit a protective immune response against tick infestations and tick-borne pathogen transmission. WO2014159052. 2014.
   Google Scholar
• Government U. AAV mediated aquaporin gene transfer to treat Sjogren’s syndrome. WO2014036468A2, US2015203553. 2014.
   Google Scholar
• Jun Xu N, CN. Elispot diagnostic kit for neuromyelitis optica and its application. US9091687, US2015140569, WO2014067229. 2015.
   Google Scholar
• The Johns Hopkins University U. Highly soluble aquaporin-4 extracellular loop C peptide immunization for treatment of neuromyelitis optica. WO2015179360. 2015.
   Google Scholar
• Coger-Simmons U, Schrum LW, Kumar BK, et al. Increased aquaporin expression on cellular membrane to improve cryopreservation efficiency. US2015024406. 2015.
   Google Scholar
• Beitz E, Golldack A, Rothert M, et al. Challenges and achievements in the therapeutic modulation of aquaporin functionality. Pharmacol Ther. 2015 Nov;155:22–35.
   PubMed Web of Science ®Google Scholar
• Esteva-Font C, Jin BJ, Lee S, et al. Experimental evaluation of proposed small-molecule inhibitors of water channel aquaporin-1. Mol Pharmacol. 2016 Jun;89(6):686–693.
   PubMed Web of Science ®Google Scholar
• Nielsen S, Frokiaer J, Marples D, et al. Aquaporins in the kidney: from molecules to medicine. Physiol Rev. 2002 Jan;82(1):205–244.
   PubMed Web of Science ®Google Scholar
• Nielsen J, Kwon TH, Christensen BM, et al. Dysregulation of renal aquaporins and epithelial sodium channel in lithium-induced nephrogenic diabetes insipidus. Semin Nephrol. 2008 May;28(3):227–244.
   PubMed Web of Science ®Google Scholar
• Izumi Y, Miura K, Iwao H. Therapeutic potential of vasopressin-receptor antagonists in heart failure. J Pharmacol Sci. 2014;124(1):1–6.
   PubMed Web of Science ®Google Scholar
• Lemmens-Gruber R, Kamyar M. Vasopressin antagonists. Cell Mol Life Sci. 2006 Aug;63(15):1766–1779.
   PubMed Web of Science ®Google Scholar
• Kanno K, Sasaki S, Hirata Y, et al. Urinary excretion of aquaporin-2 in patients with diabetes insipidus. N Engl J Med. 1995 Jun 8;332(23):1540–1545.
   PubMed Web of Science ®Google Scholar
• Wen H, Frokiaer J, Kwon TH, et al. Urinary excretion of aquaporin-2 in rat is mediated by a vasopressin-dependent apical pathway. J Am Soc Nephrol. 1999 Jul;10(7):1416–1429.
   PubMed Web of Science ®Google Scholar
• Gross P. Renal transport proteins in excreted urine: gold mine or gold dust? Kidney Int. 2004 Oct;66(4):1707–1708.
   PubMed Web of Science ®Google Scholar
• Papadopoulos MC, Verkman AS. Aquaporin-4 and brain edema. Pediatr Nephrology. 2007 Jun;22(6):778–784.
   PubMed Web of Science ®Google Scholar
• Fukuda AM, Badaut J. Aquaporin 4: a player in cerebral edema and neuroinflammation. J Neuroinflammation. 2012;9:279.
   PubMed Web of Science ®Google Scholar
• Manley GT, Fujimura M, Ma T, et al. Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke. Nat Med. 2000 Feb;6(2):159–163.
   PubMed Web of Science ®Google Scholar
• Wingerchuk DM, Lennon VA, Lucchinetti CF, et al. The spectrum of neuromyelitis optica. Lancet Neurol. 2007 Sep;6(9):805–815.
   PubMed Web of Science ®Google Scholar
• Wolburg H, Wolburg-Buchholz K, Fallier-Becker P, et al. Structure and functions of aquaporin-4-based orthogonal arrays of particles. Int Rev Cell Mol Biol. 2011;287:1–41.
   PubMed Web of Science ®Google Scholar
• Palace J, Leite MI, Jacob A. A practical guide to the treatment of neuromyelitis optica. Pract Neurol. 2012 Aug;12(4):209–214.
   PubMedGoogle Scholar
• Kowarik MC, Soltys J, Bennett JL. The treatment of neuromyelitis optica. J Neuroophthalmol. 2014 Mar;34(1):70–82.
   PubMed Web of Science ®Google Scholar
• Kitley J, Palace J. Therapeutic options in neuromyelitis optica spectrum disorders. Expert Rev Neurother. 2016;16(3):319–329.
   PubMed Web of Science ®Google Scholar
• Ferro F, Vagelli R, Bruni C, et al. One year in review 2016: Sjogren’s syndrome. Clin Exp Rheumatol. 2016 Mar-Apr;34(2):161–171.
   PubMed Web of Science ®Google Scholar
• Delporte C. Aquaporins in secretory glands and their role in Sjogren’s syndrome. Handb Exp Pharmacol. 2009;190:185–201.
   PubMedGoogle Scholar
• Morrissey JJ, Mellnick VM, Luo J, et al. Evaluation of urine aquaporin-1 and perilipin-2 concentrations as biomarkers to screen for renal cell carcinoma: a prospective cohort study. JAMA Oncology. 2015 May;1(2):204–212.
   PubMed Web of Science ®Google Scholar
• Morrissey JJ, London AN, Luo J, et al. Urinary biomarkers for the early diagnosis of kidney cancer. Mayo Clin Proc. 2010 May;85(5):413–421.
   PubMed Web of Science ®Google Scholar
• Madeira A, Moura TF, Soveral G. Detecting aquaporin function and regulation. Front Chemistry. 2016;4:3.
   PubMed Web of Science ®Google Scholar
• Rossi A, Ratelade J, Papadopoulos MC, et al. Neuromyelitis optica IgG does not alter aquaporin-4 water permeability, plasma membrane M1/M23 isoform content, or supramolecular assembly. Glia. 2012 Dec;60(12):2027–2039.
   PubMed Web of Science ®Google Scholar
• Martins AP, Marrone A, Ciancetta A, et al. Targeting aquaporin function: potent inhibition of aquaglyceroporin-3 by a gold-based compound. PLoS One. 2012;7(5):e37435.
   PubMed Web of Science ®Google Scholar
• Martins AP, Ciancetta A, De Almeida A, et al. Aquaporin inhibition by gold(III) compounds: new insights. ChemMedChem. 2013 Jul;8(7):1086–1092.
   PubMed Web of Science ®Google Scholar
• Madeira A, De Almeida A, De Graaf C, et al. A gold coordination compound as a chemical probe to unravel aquaporin-7 function. Chembiochem. 2014 Jul 7;15(10):1487–1494.
   PubMed Web of Science ®Google Scholar
• De Almeida A, Soveral G, Casini A. Gold compounds as aquaporin inhibitors: new opportunities for therapy and imaging. Med Chem Commun. 2014 Oct;5(10):1444–1453.
   Web of Science ®Google Scholar
• De Almeida A, Martins AP, Mosca AF, et al. Exploring the gating mechanisms of aquaporin-3: new clues for the design of inhibitors? Mol Biosyst. 2016 Apr 26;12(5):1564–1573.
   PubMed Web of Science ®Google Scholar
• Spinello A, De Almeida A, Casini A, et al. The inhibition of glycerol permeation through aquaglyceroporin-3 induced by mercury(II): a molecular dynamics study. J. Inorg Biochem. 2016 Jul;160:78–84.
   Web of Science ®Google Scholar